Study reveals optimal particle size for anticancer nanomedicines

10/16/2014

Jianjun Cheng has shown that there is an optimal particle size for nanomedicines. The results are important for guiding future research in designing new nanomedicines for cancer treatment.

Written by


Share this story

This story was published October 16, 2014.